CREBH Regulates Systemic Glucose and Lipid Metabolism

Access this Article

Search this Article

Abstract

The cyclic adenosine monophosphate (cAMP)-responsive element-binding protein H (CREBH, encoded by CREB3L3) is a membrane-bound transcriptional factor that primarily localizes in the liver and small intestine. CREBH governs triglyceride metabolism in the liver, which mediates the changes in gene expression governing fatty acid oxidation, ketogenesis, and apolipoproteins related to lipoprotein lipase (LPL) activation. CREBH in the small intestine reduces cholesterol transporter gene Npc1l1 and suppresses cholesterol absorption from diet. A deficiency of CREBH in mice leads to severe hypertriglyceridemia, fatty liver, and atherosclerosis. CREBH, in synergy with peroxisome proliferator-activated receptor α (PPARα), has a crucial role in upregulating Fgf21 expression, which is implicated in metabolic homeostasis including glucose and lipid metabolism. CREBH binds to and functions as a co-activator for both PPARα and liver X receptor alpha (LXRα) in regulating gene expression of lipid metabolism. Therefore, CREBH has a crucial role in glucose and lipid metabolism in the liver and small intestine.

Journal

  • International journal of molecular sciences

    International journal of molecular sciences 19(5), 1396, 2018-05

    Molecular Diversity Preservation International

Codes

  • NII Article ID (NAID)
    120006501396
  • NII NACSIS-CAT ID (NCID)
    AA12038549
  • Text Lang
    ENG
  • Article Type
    journal article
  • ISSN
    1422-0067
  • Data Source
    IR 
Page Top